Profiel
Patrick J.
Crutcher is currently the President & Chief Executive Officer at AlmataBio, Inc. Previously, he served as the Chairman & President at Ichorion Therapeutics, Inc. from 2017 to 2018.
He also worked as the Chief Strategy Officer at Avalo Therapeutics, Inc. in 2019.
Mr. Crutcher holds a graduate degree from the University of California, Los Angeles and an undergraduate degree from the University of Illinois.
Actieve functies van Patrick Crutcher
| Bedrijven | Functie | Begin |
|---|
Eerdere bekende functies van Patrick Crutcher
| Bedrijven | Functie | Einde |
|---|---|---|
| AVALO THERAPEUTICS, INC. | Corporate Officer/Principal | 01-11-2019 |
Ichorion Therapeutics, Inc.
 Ichorion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ichorion Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of treatments for rare diseases. It focuses on a pipeline of genetically-targeted therapies for inherited metabolic disorders known as Inborn Errors of Metabolism. The company was founded by Stephen Thomas on July 7, 2017 and is headquartered in New York, NY. | Algemeen Directeur | 01-09-2018 |
Opleiding van Patrick Crutcher
| University of California, Los Angeles | Graduate Degree |
| University of Illinois | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| AVALO THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Ichorion Therapeutics, Inc.
Ichorion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ichorion Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of treatments for rare diseases. It focuses on a pipeline of genetically-targeted therapies for inherited metabolic disorders known as Inborn Errors of Metabolism. The company was founded by Stephen Thomas on July 7, 2017 and is headquartered in New York, NY. | Health Technology |
